AHCPR to evaluate FDG-PET application

Article

The Agency for Health Care Policy and Research last week announcedplans to evaluate the safety and clinical value of FDG-PET fordiagnosing and managing epilepsy. The review will center on the use of FDG-PET to locate thefocus of epileptic seizures for

The Agency for Health Care Policy and Research last week announcedplans to evaluate the safety and clinical value of FDG-PET fordiagnosing and managing epilepsy.

The review will center on the use of FDG-PET to locate thefocus of epileptic seizures for possible surgical excision. Radiologistsat the University of California at Los Angeles and elsewhere havereported good results with this application since at least 1993.

The evaluation was requested by the Health Care Financing Administrationand will influence whether Medicare coverage will be extendedfor the procedure.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.